The effect of statin persistence on prognosis in acute heart failure patients

12 May 2024 (15:00 - 15:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Hyun-Jin Kim

Hanyang University Kuri Hospital, Guri (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail

Acute diuretic effect of empagliflozin in de novo heart failure: a secondary analysis of the EMPAG-HF trial

Doctor J. Bogoviku (Jena, DE)

Abstract Slides Video

Presentation thumbnail

Renal function in patients with acute decompensated de novo heart failure treated with the SGLT2 inhibitor empagliflozin: a secondary analysis of the EMPAG-HF trial

Doctor J. Bogoviku (Jena, DE)

Abstract Slides Video

Presentation thumbnail

Acute effect of empagliflozin on echocardiographic parameter in de novo heart failure: a secondary analysis of the EMPAG-HF trial

Doctor J. Bogoviku (Jena, DE)

Abstract Slides Video

Presentation thumbnail

Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction

Doctor N. Bonini (Modena, IT)

Abstract Slides Video

Presentation thumbnail

Acute diuretic response of empagliflozin according to LVEF:A secondary analysis of the EMPAG-HF trial

Doctor J. Bogoviku (Jena, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Acute heart failure - pharmacotherapy 2

The Event

Event poster

Heart Failure 2024

12 May 2024 15:00 CET

You may be interested in

Congress Presentation

Impact of statins on mortality and re-hospitalization in acute heart failure patients

Congress Presentation

Characteristics, outcomes and treatment of heart failure in women stratified by ejection fraction

Congress Presentation

Two-year outcomes of acute heart failure patients stratified by ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources